407 related articles for article (PubMed ID: 15759042)
21. Doripenem: position in clinical practice.
Dedhia HV; McKnight R
Expert Rev Anti Infect Ther; 2009 Jun; 7(5):507-14. PubMed ID: 19485791
[TBL] [Abstract][Full Text] [Related]
22. Biosynthetic genes for aminoglycoside antibiotics.
Kudo F; Eguchi T
J Antibiot (Tokyo); 2009 Sep; 62(9):471-81. PubMed ID: 19644520
[TBL] [Abstract][Full Text] [Related]
23. [Broad-spectrum beta-lactamases in Gram-negative bacteria].
Sundsfjord A; Simonsen GS; Haldorsen B; Lundblad EW; Samuelsen O
Tidsskr Nor Laegeforen; 2008 Dec; 128(23):2741-5. PubMed ID: 19079424
[TBL] [Abstract][Full Text] [Related]
24. The current state of multidrug-resistant gram-negative bacilli in North America.
Nicasio AM; Kuti JL; Nicolau DP
Pharmacotherapy; 2008 Feb; 28(2):235-49. PubMed ID: 18225969
[TBL] [Abstract][Full Text] [Related]
25. beta -Lactamases: which ones are clinically important?
Rice LB; Bonomo RA
Drug Resist Updat; 2000 Jun; 3(3):178-189. PubMed ID: 11498383
[TBL] [Abstract][Full Text] [Related]
26. Taking inventory: antibacterial agents currently at or beyond phase 1.
Bush K; Macielag M; Weidner-Wells M
Curr Opin Microbiol; 2004 Oct; 7(5):466-76. PubMed ID: 15451501
[TBL] [Abstract][Full Text] [Related]
27. Redefining penems.
Dalhoff A; Janjic N; Echols R
Biochem Pharmacol; 2006 Mar; 71(7):1085-95. PubMed ID: 16413506
[TBL] [Abstract][Full Text] [Related]
28. In vitro activities of three carbapenems against recent bacterial isolates from severely ill patients at Swedish hospitals.
Fraenkel CJ; Ullberg M; Bernander S; Ericson E; Larsson P; Rydberg J; Törnqvist E; Melhus A
Scand J Infect Dis; 2006; 38(10):853-9. PubMed ID: 17008228
[TBL] [Abstract][Full Text] [Related]
29. Activity of meropenem as serine carbapenemases evolve in US Medical Centers: monitoring report from the MYSTIC Program (2006).
Rhomberg PR; Deshpande LM; Kirby JT; Jones RN
Diagn Microbiol Infect Dis; 2007 Dec; 59(4):425-32. PubMed ID: 17662557
[TBL] [Abstract][Full Text] [Related]
30. Activity of the anti-MRSA carbapenem razupenem (PTZ601) against Enterobacteriaceae with defined resistance mechanisms.
Livermore DM; Mushtaq S; Warner M
J Antimicrob Chemother; 2009 Aug; 64(2):330-5. PubMed ID: 19497942
[TBL] [Abstract][Full Text] [Related]
31. A pheromone-independent CarR protein controls carbapenem antibiotic synthesis in the opportunistic human pathogen Serratia marcescens.
Cox ARJ; Thomson NR; Bycroft B; Stewart GSAB; Williams P; Salmond GPC
Microbiology (Reading); 1998 Jan; 144 ( Pt 1)():201-209. PubMed ID: 9467912
[TBL] [Abstract][Full Text] [Related]
32. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
[TBL] [Abstract][Full Text] [Related]
33. Beta-lactam antibiotic resistance: a current structural perspective.
Wilke MS; Lovering AL; Strynadka NC
Curr Opin Microbiol; 2005 Oct; 8(5):525-33. PubMed ID: 16129657
[TBL] [Abstract][Full Text] [Related]
34. Antimicrobial resistance among and therapeutic options against gram-negative pathogens.
Rahal JJ
Clin Infect Dis; 2009 Aug; 49 Suppl 1():S4-S10. PubMed ID: 19619021
[TBL] [Abstract][Full Text] [Related]
35. Characterization of biosynthetic gene cluster for the production of virginiamycin M, a streptogramin type A antibiotic, in Streptomyces virginiae.
Pulsawat N; Kitani S; Nihira T
Gene; 2007 May; 393(1-2):31-42. PubMed ID: 17350183
[TBL] [Abstract][Full Text] [Related]
36. The threat of antibiotic resistance in Gram-negative pathogenic bacteria: beta-lactams in peril!
Thomson JM; Bonomo RA
Curr Opin Microbiol; 2005 Oct; 8(5):518-24. PubMed ID: 16126451
[TBL] [Abstract][Full Text] [Related]
37. Comparative activity of doripenem and three other carbapenems tested against Gram-negative bacilli with various beta-lactamase resistance mechanisms.
Jones RN; Sader HS; Fritsche TR
Diagn Microbiol Infect Dis; 2005 May; 52(1):71-4. PubMed ID: 15878447
[TBL] [Abstract][Full Text] [Related]
38. Analysis of bacterial carbapenem antibiotic production genes reveals a novel beta-lactam biosynthesis pathway.
McGowan SJ; Sebaihia M; Porter LE; Stewart GS; Williams P; Bycroft BW; Salmond GP
Mol Microbiol; 1996 Nov; 22(3):415-26. PubMed ID: 8939426
[TBL] [Abstract][Full Text] [Related]
39. Evolution of beta-lactam biosynthesis genes and recruitment of trans-acting factors.
Brakhage AA; Al-Abdallah Q; Tüncher A; Spröte P
Phytochemistry; 2005 Jun; 66(11):1200-10. PubMed ID: 15950251
[TBL] [Abstract][Full Text] [Related]
40. [Beta-lactamases in laboratory and their role in resistance Part I.: Evolution of bacterial resistance mediated by beta-lactamases].
Bedenić B
Lijec Vjesn; 2004; 126(11-12):314-24. PubMed ID: 16082890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
